How Nuclear Magnetic Resonance Spectroscopy is Being Used to Regulate Therapeutic Proteins

3 February 2017

Hear from Yves Aubin, Research Scientist at the Biologics and Genetics Therapies Directorate, Health Canada, describe the use of nuclear magnetic resonance spectroscopy for the characterization of protein therapeutics and polysaccharide vaccines. Yves is responsible for regulation of biologics products to ensure their safety and efficacy.